Related Experiment Video
Updated: Aug 9, 2025

Author Spotlight: Unraveling Vitamin A Transport Mechanisms — Linking Liver Receptors to Vision Health Through RBPR2 and RBP4 Interactions
Published on: October 4, 2024
p57Kip2 is an essential regulator of vitamin D receptor-dependent mechanisms
Katsuhiko Takahashi1,2, Hitoshi Amano1,3,4, Tomohiko Urano5,6
1Department of Biochemistry, Hoshi University, Ebara, Shinagawa-ku, Tokyo.
Abstract:
A cyclin-dependent kinase (CDK) inhibitor, p57Kip2, is an important molecule involved in bone development; p57Kip2-deficient (p57-/-) mice display neonatal lethality resulting from abnormal bone formation and cleft palate. The modulator 1α,25-dihydroxyvitamin D3 (l,25-(OH)2VD3) has shown the potential to suppress the proliferation and induce the differentiation of normal and tumor cells. The current study assessed the role of p57Kip2 in the 1,25-(OH)2VD3-regulated differentiation of osteoblasts because p57Kip2 is associated with the vitamin D receptor (VDR). Additionally, 1,25-(OH)2VD3 treatment increased p57KIP2 expression and induced the colocalization of p57KIP2 with VDR in the osteoblast nucleus. Primary p57-/- osteoblasts exhibited higher proliferation rates with Cdk activation than p57+/+ cells. A lower level of nodule mineralization was observed in p57-/- osteoblasts than in p57+/+ cells. In p57+/+ osteoblasts, 1,25-(OH)2VD3 upregulated the p57Kip2 and opn mRNA expression levels, while the opn expression levels were significantly decreased in p57-/- cells. The osteoclastogenesis assay performed using bone marrow cocultured with 1,25-(OH)2VD3-treated osteoblasts revealed a decreased efficiency of 1,25-(OH)2VD3-stimulated osteoclastogenesis in p57-/- cells. Based on these results, p57Kip2 might function as a mediator of 1,25-(OH)2VD3 signaling, thereby enabling sufficient VDR activation for osteoblast maturation.
Insights
The study reveals that p57Kip2 is crucial for vitamin D
Area of Science:
- Molecular Biology
- Developmental Biology
- Cell Biology
Background:
- p57Kip2 is a cyclin-dependent kinase inhibitor vital for bone development.
- p57Kip2 deficiency in mice leads to neonatal lethality due to bone and palate abnormalities.
- 1α,25-dihydroxyvitamin D3 (1,25-(OH)2VD3) influences cell proliferation and differentiation.
Purpose of the Study:
- To investigate the role of p57Kip2 in 1,25-(OH)2VD3-regulated osteoblast differentiation.
- To understand the association between p57Kip2 and the vitamin D receptor (VDR).
Main Methods:
- Assessed p57Kip2 expression and localization with VDR in osteoblasts.
- Compared proliferation and mineralization in p57Kip2-deficient (p57-/-) and wild-type (p57+/+) osteoblasts.
- Analyzed mRNA expression of p57Kip2 and osteopontin (opn) following 1,25-(OH)2VD3 treatment.
- Evaluated osteoclastogenesis using co-cultures with treated osteoblasts.
Main Results:
- 1,25-(OH)2VD3 increased p57Kip2 expression and nuclear co-localization with VDR.
- p57-/- osteoblasts showed increased proliferation and reduced mineralization compared to p57+/+ cells.
- 1,25-(OH)2VD3 upregulated p57Kip2 and opn mRNA in p57+/+ cells, but opn was decreased in p57-/- cells.
- Osteoclastogenesis was less efficient in p57-/- cells treated with 1,25-(OH)2VD3.
Conclusions:
- p57Kip2 acts as a mediator in 1,25-(OH)2VD3 signaling pathways.
- Sufficient VDR activation for osteoblast maturation depends on p57Kip2.
- p57Kip2 is essential for normal bone development regulated by vitamin D.
Related Concept Videos
Role of Skin in Vitamin D Synthesis
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
Negative Regulator Molecules
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Abnormal Proliferation
Inhibition of Cdk Activity
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...

